GCC Syringes and Needles Market is expected to reach a valuation of US$ 1.33 Billion by 2031 | FMI Analyst

According to a Future Market Insights (FMI) study, the GCC Syringes and Needles Market was valued at US$ 525.4 Million in 2020 and is expected to reach US$ 1.33 Billion by 2031, growing at an 8.8% CAGR from 2021 to 2031. GCC countries have been prioritizing their healthcare sector owing to the increasing population along …

With a 31.2% share of the Molecular Cytogenetics Market, North America is expected to be the most opportunistic | FMI Study

The global Molecular Cytogenetics Market demand is anticipated to reach US$ 2,761.9 million in 2022, with a predicted CAGR of 8.9% from 2022 to 2032. The advancement is credited to changing techniques for disease diagnosis, rising amounts of government support in various jurisdictions, and increased public knowledge of viral infections. From 2016 to 2021, the …

Drug Formulation Market is expected to reach US$ 2.87 Trillion by 2032, at a CAGR 5.6%

The global demand for drug formulation is projected to grow at a CAGR of 5.6% between 2022 and 2032, with the pharmaceutical formulations market expected to reach a value of $1.58 trillion by 2022. According to the study, oral formulations are anticipated to experience exponential growth, with a CAGR of 6.0% during the forecast period. …

Inhalation and Nasal Spray Generic Drugs Market is likely to CAGR of 8.96% by 2032

During the forecast period, the global Inhalation and Nasal Spray Generic Drugs Market is expected to grow at a moderate rate of 8.96%. The market for inhalation and nasal spray generic pharmaceuticals is currently valued at US$ 20.78 billion in 2023. The market for inhalation and nasal spray generic pharmaceuticals is expected to reach a …

Automated Cell Biology Systems Market is expected to reach US$ 33.5 Billion by 2032

According to Future Market Insights’ most recent industry report, the global automated cell biology systems market stands at US$ 14.1 Billion in 2022 and is expected to rise at a CAGR close to 9.0% over the forecast period, with an anticipated worth of around US$ 33.5 Billion in 2032. The development of powerful new technologies …

Interferons Market is anticipated to reach US$ 13.8 Billion by the end of 2032

As per a latest industry analysis by Future Market Insights, the global interferons market  for interferons is anticipated to reach US$ 9.4 billion in 2022 and continue to grow at a CAGR of 3.9% from 2022 to 2032. By the end of 2032, the global market is projected to reach US$ 13.8 billion. A group of …

Europe Radiotherapy Patient Positioning Market is set at 4.1% CAGR from 2022 to 2032

As per Future Market Insights’ latest revised industry analysis, the Europe radiotherapy patient positioning market was radiotherapy patient positioning in Europe is anticipated to increase significantly between 2022 and 2032, with a 4.1% CAGR, topping US$ 124.9 Million in 2022. In terms of product type, the markers market will account for a sizeable portion of the …

Sinus Therapeutic Drugs Market is expected to witness a CAGR of over 6.3% by 2030

The global sinus therapeutic drugs market will Between 2020 and 2030, the market for sinus therapeutic pharmaceuticals is anticipated to grow at a CAGR of more than 6.3%. The development of biologics is amongst the most important factors catalysing the sinus therapeutic drugs market. Omalizumab is garnering interest of researchers and drug manufacturers alike. It has …

Surgical Booms Market is projected to grow at a moderate CAGR of 4.7% by 2022 and 2029

Surgical booms are also known as Equipment Management Systems (EMS). Surgical booms are used to constrain electrical wiring from the various equipment used in the OR. They also help organise the space in the OR by increasing the working space. Most surgical booms are suspended from the roof of the OR and are available in …

Biopsy Device Market is expand at a CAGR of 4.9% by 2023 and 2033

The Market report envelopes an all-in information of the Global Biopsy Device Market and the nature of the Market growth over the foreseeable period. In 2023, it is predicted that the global market for biopsy devices would be valued US$ 2.1 billion. By the end of 2033, the market is anticipated to be worth US$ 3.3 billion, …